Search Results

Filipinos have often been classified as a race having low risk for developing prostate cancer (CaP), and likewise a low risk of dying from the disease. This has mostly been based on information indicating similar patterns among men of Asian decent. But with the changing trends in the disease, both worldwide and in the Asian region, should Filipinos continue to be regarded as such? To attempt to answer this question, a literature search was performed using the following online databases: Medline, SUMsearch, CancerLit, and National Library of Medicine Gateway. The search terms used were "prostate cancer," "Filipino," "Asians," "incidence," and "prognosis." A total of 39 publications were included in this review. In all the studies that segregated Asians into its component subpopulations, Filipinos were noted to have the highest incidence rate (IR) among Asians residing locally, and also the highest or second highest IR among Asian immigrants residing abroad. Studies that focused on the Asian region consistently found an increasing trend in IR of CaP for all subpopulations, with the Philippines experiencing one of the fastest rising IR. Filipinos, both residing abroad and locally, were also observed to have the highest mortality rate (MR) among all the Asian subpopulations included, with an even higher MR than Caucasians reported by certain studies. Evidence was found in this review suggesting that Filipino men may not have the low risk of developing and dying from CaP, as is popularly believed, and may have similar risk of death from CaP as Caucasians.

Human ; Male ; Prostatic Neoplasms ; Neoplasms ; Genital Neoplasms, Male ; Continental Population Groups ; Databases, Bibliographic

OBJECTIVETo explore the clinical features and treatment of spermatic cord liposarcoma (SCL).

METHODSWe retrospectively analyzed the clinical data of a case of SCL, reviewed the related literature and investigated the diagnosis and treatment of the disease.

RESULTSThe patient underwent tumor resection and left inguinal orchidectomy. Postoperative pathology confirmed the case to be s SCL. Neither recurrence nor metastasis was found during the five-month follow-up.

CONCLUSIONSCL is a rare medical condition with no specific imaging and laboratory features. Radical orchidectomy with wide local excision of the mass is recommended for its treatment, and adjuvant radiotherapy can be considered in intermediately or highly differentiated tumors and recurrent liposarcomas, while the role of chemotherapy is not well-defined.